254 related articles for article (PubMed ID: 25748296)
41. Longitudinal trajectories of metabolic syndrome on different neurocognitive domains: a cohort study from the Taiwan biobank.
Wu SE; Chen WL
Aging (Albany NY); 2021 Jun; 13(11):15400-15412. PubMed ID: 34114969
[TBL] [Abstract][Full Text] [Related]
42. Differential Impact of Neurofilament Light Subunit on Cognition and Functional Outcome in Memory Clinic Patients with and without Vascular Burden.
Rolstad S; Berg AI; Eckerström C; Johansson B; Wallin A
J Alzheimers Dis; 2015; 45(3):873-81. PubMed ID: 25633679
[TBL] [Abstract][Full Text] [Related]
43. Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project.
van Maurik IS; Slot RER; Verfaillie SCJ; Zwan MD; Bouwman FH; Prins ND; Teunissen CE; Scheltens P; Barkhof F; Wattjes MP; Molinuevo JL; Rami L; Wolfsgruber S; Peters O; Jessen F; Berkhof J; van der Flier WM;
Alzheimers Res Ther; 2019 Apr; 11(1):33. PubMed ID: 30987684
[TBL] [Abstract][Full Text] [Related]
44. Performance of cognitive tests, individually and combined, for the detection of cognitive disorders amongst community-dwelling elderly people with memory complaints: the EVATEM study.
Vannier-Nitenberg C; Dauphinot V; Bongue B; Sass C; Bathsavanis A; Rouch I; Deville N; Beauchet O; Krolak-Salmon P; Fantino B
Eur J Neurol; 2016 Mar; 23(3):554-61. PubMed ID: 26518736
[TBL] [Abstract][Full Text] [Related]
45. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
46. Open referral policy within a nurse-led memory clinic: patient demographics, assessment scores, and diagnostic profiles.
Minstrell M; Bentley M; Bucher H; Morrissey M; Higgs C; Robinson A; Stirling C
Int Psychogeriatr; 2015 Jun; 27(6):967-79. PubMed ID: 25483359
[TBL] [Abstract][Full Text] [Related]
47. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
[TBL] [Abstract][Full Text] [Related]
48. Predicting decline in mild cognitive impairment: a prospective cognitive study.
Belleville S; Gauthier S; Lepage E; Kergoat MJ; Gilbert B
Neuropsychology; 2014 Jul; 28(4):643-52. PubMed ID: 24588699
[TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
50. Functional magnetic resonance imaging response as an early biomarker of cognitive decline in elderly patients with metabolic syndrome.
Shigaeff N; Amaro E; Franco FGM; Jacinto AF; Chiochetta G; Cendoroglo MS; Citero VA
Arch Gerontol Geriatr; 2017 Nov; 73():1-7. PubMed ID: 28711765
[TBL] [Abstract][Full Text] [Related]
51. Can mild cognitive impairment be accurately diagnosed in english speakers from linguistic minorities? Results from the Sydney Memory and Ageing study.
Low LF; Harrison F; Kochan NA; Draper B; Slavin MJ; Reppermund S; Sachdev PS; Brodaty H
Am J Geriatr Psychiatry; 2012 Oct; 20(10):866-77. PubMed ID: 22261551
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic--comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study.
Pusswald G; Moser D; Gleiss A; Janzek-Hawlat S; Auff E; Dal-Bianco P; Lehrner J
Alzheimers Dement; 2013 Jul; 9(4):366-76. PubMed ID: 23164551
[TBL] [Abstract][Full Text] [Related]
53. Predictor of cognitive impairment: metabolic syndrome or circadian syndrome.
Liu Y; Zang B; Shao J; Ning N; He L; Ma Y
BMC Geriatr; 2023 Jul; 23(1):408. PubMed ID: 37403015
[TBL] [Abstract][Full Text] [Related]
54. Association between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline.
Lai MMY; Ames DJ; Cox KL; Ellis KA; Sharman MJR; Hepworth G; Desmond P; Cyarto EV; Szoeke C; Martins R; Masters CL; Lautenschlager NT
J Nutr Health Aging; 2020; 24(3):300-304. PubMed ID: 32115611
[TBL] [Abstract][Full Text] [Related]
55. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.
Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H;
Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517
[TBL] [Abstract][Full Text] [Related]
56. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.
Buchhave P; Minthon L; Zetterberg H; Wallin AK; Blennow K; Hansson O
Arch Gen Psychiatry; 2012 Jan; 69(1):98-106. PubMed ID: 22213792
[TBL] [Abstract][Full Text] [Related]
57. Differences in quantitative methods for measuring subjective cognitive decline - results from a prospective memory clinic study.
Vogel A; Salem LC; Andersen BB; Waldemar G
Int Psychogeriatr; 2016 Sep; 28(9):1513-20. PubMed ID: 27053171
[TBL] [Abstract][Full Text] [Related]
58. Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population.
Prins ND; van der Flier WM; Brashear HR; Knol DL; van de Pol LA; Barkhof F; Scheltens P
J Alzheimers Dis; 2013; 36(1):79-85. PubMed ID: 23563246
[TBL] [Abstract][Full Text] [Related]
59. Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study.
Eckerström C; Olsson E; Klasson N; Berge J; Nordlund A; Bjerke M; Wallin A
J Alzheimers Dis; 2015; 44(1):205-14. PubMed ID: 25201779
[TBL] [Abstract][Full Text] [Related]
60. Metabolic Syndrome and Cognitive Trajectories in the Framingham Offspring Study.
Bangen KJ; Armstrong NM; Au R; Gross AL
J Alzheimers Dis; 2019; 71(3):931-943. PubMed ID: 31450495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
